8-144511718-G-A
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_004260.4(RECQL4):c.3465C>T(p.Phe1155Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000695 in 1,612,470 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: 𝑓 0.000066   (  0   hom.,  cov: 34) 
 Exomes 𝑓:  0.000070   (  0   hom.  ) 
Consequence
 RECQL4
NM_004260.4 synonymous
NM_004260.4 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  1.07  
Publications
1 publications found 
Genes affected
 RECQL4  (HGNC:9949):  (RecQ like helicase 4) The protein encoded by this gene is a DNA helicase that belongs to the RecQ helicase family. DNA helicases unwind double-stranded DNA into single-stranded DNAs and may modulate chromosome segregation. This gene is predominantly expressed in thymus and testis. Mutations in this gene are associated with Rothmund-Thomson, RAPADILINO and Baller-Gerold syndromes. [provided by RefSeq, Jan 2010] 
RECQL4 Gene-Disease associations (from GenCC):
- Baller-Gerold syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet
- Rothmund-Thomson syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Rothmund-Thomson syndrome type 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- osteosarcomaInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- rapadilino syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52). 
BP6
Variant 8-144511718-G-A is Benign according to our data. Variant chr8-144511718-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 459483.Status of the report is criteria_provided_single_submitter, 1 stars. 
BP7
Synonymous conserved (PhyloP=1.07 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000657  AC: 10AN: 152254Hom.:  0  Cov.: 34 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
10
AN: 
152254
Hom.: 
Cov.: 
34
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000242  AC: 6AN: 247664 AF XY:  0.0000296   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
6
AN: 
247664
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000699  AC: 102AN: 1460216Hom.:  0  Cov.: 36 AF XY:  0.0000592  AC XY: 43AN XY: 726384 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
102
AN: 
1460216
Hom.: 
Cov.: 
36
 AF XY: 
AC XY: 
43
AN XY: 
726384
show subpopulations 
African (AFR) 
 AF: 
AC: 
1
AN: 
33480
American (AMR) 
 AF: 
AC: 
0
AN: 
44720
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26132
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39700
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
86252
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
52032
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5766
European-Non Finnish (NFE) 
 AF: 
AC: 
92
AN: 
1111790
Other (OTH) 
 AF: 
AC: 
9
AN: 
60344
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 6 
 12 
 18 
 24 
 30 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 4 
 8 
 12 
 16 
 20 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000657  AC: 10AN: 152254Hom.:  0  Cov.: 34 AF XY:  0.0000672  AC XY: 5AN XY: 74386 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
10
AN: 
152254
Hom.: 
Cov.: 
34
 AF XY: 
AC XY: 
5
AN XY: 
74386
show subpopulations 
African (AFR) 
 AF: 
AC: 
2
AN: 
41466
American (AMR) 
 AF: 
AC: 
1
AN: 
15292
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5202
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4836
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10628
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
7
AN: 
68040
Other (OTH) 
 AF: 
AC: 
0
AN: 
2090
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.500 
Heterozygous variant carriers
 0 
 1 
 2 
 3 
 4 
 5 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Baller-Gerold syndrome    Benign:1 
Dec 09, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.